Chronic Hepatitis B Infection Diagnosis and Management

Key Serologic Interpretation

The presence of HBeAg positivity with absent anti-HBe antibodies indicates active viral replication and high infectivity, according to the Centers for Disease Control and Prevention 1, 2
HBsAg positive confirms HBV infection, as stated by the Centers for Disease Control and Prevention 3
HBeAg positive with anti-HBe negative indicates high viral replication and the immune tolerant or immune active phase, as reported by the European Association for the Study of the Liver 1, 4
HBV IgM negative rules out acute infection in most cases, though IgM anti-HBc appears at symptom onset in acute infection, according to the Centers for Disease Control and Prevention 2, 3
Normal ALT/AST is consistent with immune tolerant phase where minimal hepatocellular damage occurs despite high viral replication, as stated by the European Association for the Study of the Liver 1, 4

This patient is in Phase 1 (immune tolerant phase) or early Phase 2 (immune active phase) of chronic HBV infection, characterized by HBeAg positive, high HBV DNA, normal or minimally elevated ALT, and minimal liver inflammation, as classified by the European Association for the Study of the Liver 1, 4
Patients in this phase are highly contagious due to high HBV DNA levels, as reported by the European Association for the Study of the Liver 1
The rate of spontaneous HBeAg loss is very low in this phase, according to the European Association for the Study of the Liver 1

Despite normal liver enzymes, this patient requires close monitoring, including HBV DNA quantification and serial ALT monitoring every 3-4 months, as recommended by the European Association for the Study of the Liver 1, 5
The patient remains at risk for progression to cirrhosis and hepatocellular carcinoma, as stated by the Centers for Disease Control and Prevention 1, 2
The asymptomatic presentation with normal liver enzymes does not exclude significant ongoing viral replication or future disease progression, according to the European Association for the Study of the Liver 1

The American Association for the Study of Liver Diseases and the European Association for the Study of the Liver confirm that HBsAg positive for >6 months implies chronic HBV infection, as seen in patients with blood transfusion history 6, 7
The presence of HBV IgG positive (anti-HBc total) confirms chronic rather than acute infection, with a high viral replication phase indicated by HBeAg positivity and anti-HBe negativity 6
The European Association for the Study of the Liver defines inactive carriers as having HBeAg negative, anti-HBe positive, and HBV DNA <2,000 IU/mL, which is not applicable to this patient's serologic profile 7

The European Association for the Study of the Liver recommends treatment for HBeAg-positive patients with HBV DNA levels typically >20,000 IU/mL, even with normal ALT, depending on age, family history, and fibrosis assessment 7